Kiromic BioPharma, Inc.
KRBP · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $23,462 | $28,648 | $88,557 | $524,096 |
| - Cash | $1,137 | $3,204 | $645 | $25,354 |
| + Debt | $14,568 | $15,543 | $9,410 | $455 |
| Enterprise Value | $36,893 | $40,987 | $97,322 | $499,196 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$2,796 | -$2,068 | -$470 |
| % Margin | – | – | – | – |
| EBITDA | -$23,774 | -$16,301 | -$32,497 | -$25,107 |
| % Margin | – | – | – | – |
| Net Income | -$26,898 | -$21,294 | -$38,181 | -$25,654 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.03 | -21.41 | -70.12 | -67.4 |
| % Growth | 95.2% | 69.5% | -4% | – |
| Operating Cash Flow | -$19,458 | -$21,225 | -$23,746 | -$20,322 |
| Capital Expenditures | -$366 | -$207 | -$4,881 | -$1,895 |
| Free Cash Flow | -$19,824 | -$21,432 | -$28,626 | -$22,216 |